GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Compumedics Ltd (ASX:CMP) » Definitions » Total Liabilities

Compumedics (ASX:CMP) Total Liabilities : A$22.65 Mil (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Compumedics Total Liabilities?

Compumedics's Total Liabilities for the quarter that ended in Dec. 2023 was A$22.65 Mil.

Compumedics's quarterly Total Liabilities increased from Dec. 2022 (A$22.85 Mil) to Jun. 2023 (A$22.89 Mil) but then declined from Jun. 2023 (A$22.89 Mil) to Dec. 2023 (A$22.65 Mil).

Compumedics's annual Total Liabilities increased from Jun. 2021 (A$16.39 Mil) to Jun. 2022 (A$18.12 Mil) and increased from Jun. 2022 (A$18.12 Mil) to Jun. 2023 (A$22.89 Mil).


Compumedics Total Liabilities Historical Data

The historical data trend for Compumedics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Compumedics Total Liabilities Chart

Compumedics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.34 13.73 16.39 18.12 22.89

Compumedics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.22 18.12 22.85 22.89 22.65

Compumedics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Compumedics's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=21.188+(1.56+-6.5225602696728E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0.076+0.067)
=22.89

Total Liabilities=Total Assets (A: Jun. 2023 )-Total Equity (A: Jun. 2023 )
=41.182-18.291
=22.89

Compumedics's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=21.486+(1.088+0.075999999999998
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=22.65

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=40.682-18.032
=22.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Compumedics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Compumedics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Compumedics (ASX:CMP) Business Description

Traded in Other Exchanges
N/A
Address
30-40 Flockhart Street, Abbotsford, Melbourne, VIC, AUS, 3067
Compumedics Ltd is a medical device company. It is engaged in the development, manufacture, and commercialisation of diagnostic technologies for sleep, brain and ultrasonic blood-flow monitoring applications. The company is organized into geographical operating segments, being the United States of Americas, Australia and the Asia Pacific, and Europe and the Middle East. It derives a majority of its revenue from Australia and the Asia Pacific region.